At UCB, we know we’re stronger when we work together. Read more from Patty Fritz, VP of U.S. Corporate Affairs, about how UCB adapted in response to the COVID-19 pandemic to met the new unique needs of the patients, caregivers, health care providers, and health systems we’re committed to serving.

UCB has been making ongoing adjustments to ensure continuous care for patients, including people living with immune-mediated inflammatory diseases during this time of great isolation. Hear more from UCB's Head of U.S. Immunology, Camille Lee, about our efforts to better support patients during this time.

Congratulations to Andrea Loewendorf – Head, Market Access and Innovation Strategy, Neurology and Jessica Williamson, PhD – Protein Production Lead for their recognition as a Healthcare Businesswomen's Association (HBA) Rising Stars for 2020!

Patients are at the heart of everything we do, and UCB is committed to helping those impacted by the novel coronavirus, COVID-19. This includes helping patients maintain access to and answering any questions about UCB medicines, as well as putting patient and community care first in all our actions during these uncertain times.

Serving others is in our DNA at UCB – from committing to patients in our daily jobs to finding ways to make a difference in our communities through volunteerism. Each year, UCB employees get 32-hours of time off to volunteer their time at non-profits of their choice, and COVID-19 has not slowed us down from using those hours to help others during this difficult time. This National Volunteer Week, we’re celebrating our employees, whose selfless efforts during this COVID-19 pandemic inspire us.

During the COVID-19 pandemic, we’re reminded of the many challenges facing our world. At UCB, we recognize the challenges facing the world, from climate change to rising inequalities, are inextricably linked and that businesses have a key role to play to ensure a sustainable future for all. This Earth Day, we’re highlighting some of our progress as it relates to minimizing our environmental footprint across the value chain.

With the U.S. heavily impacted by the novel coronavirus, COVID-19, UCB is committed to playing our part to contribute our scientific expertise and resources to the greater response effort happening across the country and the world. This includes expanding our assistance programs to further help patients impacted by the pandemic.

The emergency department is a common point of medical intervention for epilepsy patients. We recognize there are more than one million visits to the emergency department every year for epilepsy-related seizures . These visits are not only a significant cost to the healthcare system, but also often leave patients with questions and unease related to their epilepsy diagnosis. The Centers for Disease Control and Prevention (CDC) has also recognized epilepsy as a public health challenge where patients need more skills and resources to manage their condition effectively. That’s why UCB Inc. is working with Indiana University School of Nursing to address existing gaps in care when it comes to emergency department visits and epilepsy care.

Since 2015, our Patient Value Strategy has been the driver of UCB’s approach to delivering value for patients. Our operational model puts patients and their individual experiences at the heart of everything we do – from discovery to development to delivery.

At UCB, we innovate to bring differentiated solutions with unique outcomes that help specific patients achieve their goals. To do this, we always start with the patient – listening to their experiences, what they value, and what their needs are – keeping them at the heart of everything we do. In honor of Patient Recognition Week, check out a few stories that inspire us to continue to invest in research, expand our scientific understanding, and deliver solutions that provide patients the best individual experience.